|  Home  |Search   |  Browse  |Similarity   |Data Visualization  |Submission  |Contact Us  |  
BioPhytMol Help
................................
Architecture
................................
BioPhytMol Statistics
................................
Plant Distribution
................................
Physicochemical Properties
................................
Prioritized Drug-like BioPhytMol Compounds:
Based on Physicochemical Properties
................................
SysBorg2.osdd.net
................................
Useful Resources
................................
Contact Us
................................

BioPhytMol Statistics:



Table - 1: General information about BioPhytMol

Total entriesUnique plant familiesUnique speciesNumber of phytomoleculesType of target bacteria
258218880863325


Table - 2: Statistics of molecular properties of BioPhytMol molecules

DescriptorsMeanMinMax
Molecular Weight 356.9374.082094.44
XLogP5.01-2.631.91
H_bond acceptors4.05045
H_bond donors1.40017
No. of rotatable bonds4.97048
Topological Polar Surface Area65.120649.39
No. of rings3.06010


Figure- 1: Molecular weight distribution of BioPhytMol compounds

[Top]


Figure- 2: Hydrogen bond donor distribution of BioPhytMol compounds

[Top]


Figure- 3: Hydrogen bond acceptor distribution of BioPhytMol compounds

[Top]


Figure- 4: XLogP distribution of BioPhytMol compounds

[Top]


Figure- 5: No. of rotatable bonds distribution of BioPhytMol compounds

[Top]


Figure- 6: Polar surface area distribution of BioPhytMol compounds

[Top]


Figure- 7: Molecular weight distribution comparison between BioPhytMol compounds, FDA approved small molecule drugs from Drugbank, FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs

[Top]


Figure- 8: Hydrogen bond donor distribution comparison between BioPhytMol compounds, FDA approved small molecule drugs from Drugbank, FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs

[Top]


Figure- 9: Hydrogen bond acceptor distribution comparison between BioPhytMol compounds, FDA approved small molecule drugs from Drugbank, FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs

[Top]


Figure- 10: XLogP distribution comparison between BioPhytMol compounds, FDA approved small molecule drugs from Drugbank, FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs

[Top]


Figure- 11: Number of rotatable bonds distribution comparison between BioPhytMol compounds, FDA approved small molecule drugs from Drugbank, FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs

[Top]


Figure- 12:Polar surface area distribution comparison between BioPhytMol compounds, FDA approved small molecule drugs from Drugbank, FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs

[Top]


Figure- 13: Distribution of BioPhytMol compounds against various Mycobacterial Species
[Top]



Developed and Hosted by: CSIR- Open Source Drug Discovery Unit, Delhi, India.
The website has been tested on the latest version of Google Chrome (34.0.1847.137 m) and Mozilla Firefox (29.0.1)